COVAXIN, India's First COVID-19 Vaccine Candidate, Set For Phase I, II Human Trials

(58)

Covaxin phase-3 trial will begin as second trial has successful results | India | Corona Vaccine

(1:12)

COVAXIN Phase-II Human Trials To Begin In September | Breaking News

(26)

COVID-19 Crisis: Phase-II Human Trials For Bharat Biotech's COVAXIN Vaccine To Commence In September

(3:7)

Covaxin Phase 1 Trial Clears Lancet Review, Phase 3 Trial Ongoing

(9:11)

Bharat Biotech Covaxin phase III trial is approved by Subject Expert Committee with 77.8% efficacy

(1:44)

Coronavirus Updates: Phase 2 Trial Of Covaxin To Begin In September

(1:24)

Covid-19 Vaccine: Covaxin Phase 3 Trial Data Shared With Expert Panel Which Meets Today

(2:17)

Bharat Biotech releases Covaxin's price ahead of India's phase 3 of vaccination | COVID-19 Vaccine

(2:54)

Bharat Biotech Phase 3 Results | Covaxin releases their interim analysis from phase three trials

(3:36)

Phase-1 Clinical Trials For Covaxin

(1:45)

Bharat Biotech Announces Phase 3 Results of Covaxin, Says It Shows Interim Efficacy of 81%| Breaking

(1:5)

Covid update: Covaxin’s phase 3 trials; free vaccine promise; SII’s partnership

(2:48)

Covid vaccine: Covaxin phase 3 trials on 3,000 people in UP, says minister

(2:30)

India Fights Back : COVAXIN Phase-II Trial Results | Episode - 176

(25:51)

Covaxin Shows Interim Efficacy Of 81% In Phase 3 Results: Bharat Biotech

(2:42)

Coronavirus Vaccine | Covaxin Recommended For Next Phase Of Trials For 2-18 Age Group: Report

(3:4)

Bharat Biotech's Covaxin Assures Beneficiaries Of Compensation In Case Of Adverse Effects

(50)

Bharat Biotech Enrols Over 25,000 Volunteers For Covaxin Phase 3 Trial

(2:23)

Bharat Biotech's Covaxin Shows 77.8% Efficacy Rate In Phase 3 Trial

(4:56)

Covaxin Shows 77% Efficacy In Phase 3 Trials, Bharat Biotech Informs Govt Panel, Data Under Review

(2:31)

Bharat Biotech's Covaxin Recommended By Expert Panel For Phase 2/3 Trials On Children

(3:52)

Covid-19 Vaccine: Bharat Biotech Releases Covaxin's Phase 3 Trial Data, Claims 77.8% Efficacy

(10:26)

Covaxin 77.8% Effective In Phase 3 Trial Data: Sources

(2:55)

Phase III Trials Of Bharat Biotech's Covaxin | CNBC-TV18

(2:11)

Covaxin shows 77.8% efficacy in phase 3 trial data: All you need to know | Covid

(1:52)